Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elubrixin (SB-656933) in Cystic Fibrosis
NCT00903201Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of elubrixin in cystic fibrosis (CF), sponsored by GSK. Started Sep 2009; status: completed.
02
Drugs
elubrixin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00903201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903201.